| Yang, Yan |
NCT05058040: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) |
|
|
| Active, not recruiting | 4 | 2500 | RoW | Sodium Oligomannate Capsules | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 04/24 | 04/25 | | |
| Recruiting | 3 | 918 | Europe, Canada, Japan, RoW | Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil | Jazz Pharmaceuticals, BeiGene, Ltd. | Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma | 12/24 | 07/25 | | |
NCT05862337: Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence. |
|
|
| Recruiting | 3 | 480 | RoW | Anlotinib hydrochloride capsules, Penpulimab injection, Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Hepatocellular Carcinoma | 08/24 | 12/26 | | |
NCT05180734: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer |
|
|
| Recruiting | 3 | 680 | RoW | JS001/Placebo, Postoperative Adjuvant Chemotherapy, JS001/placebo combine with Postoperative Adjuvant Chemotherapy | Shanghai Junshi Bioscience Co., Ltd. | Gastric or Esophagogastric Junction Adenocarcinoma | 03/26 | 07/28 | | |
NCT03500380: A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases |
|
|
| Active, not recruiting | 2/3 | 301 | RoW | RC48-ADC, RC48, Lapatinib, Capecitabine | RemeGen Co., Ltd. | Breast Neoplasms, Breast Diseases, Capecitabine, HER2-positive Breast Cancer, HER2 Positive Breast Carcinoma, HER2-positive Advanced Breast With Liver Metastases | 07/24 | 12/24 | | |
NCT05192798: Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC |
|
|
| Recruiting | 2 | 128 | RoW | Albumin-Bound Paclitaxel, Apatinib Mesylate, Bevacizumab | First Affiliated Hospital Bengbu Medical College | Triple-negative Breast Cancer | 01/25 | 06/25 | | |
NCT04970121: Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients With Taxanes-induced Painful Peripheral Neuropathy |
|
|
| Recruiting | 2 | 100 | RoW | Duloxetine, Chemotherapy containing taxanes | Yan Yang, MD, Ph.D | Chemotherapy-induced Peripheral Neuropathy, Pain, Solid Tumor | 07/24 | 01/25 | | |
NCT05693142: AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD) |
|
|
| Recruiting | 1/2 | 18 | US | RGX-202 | REGENXBIO Inc. | Duchenne Muscular Dystrophy | 12/25 | 12/25 | | |
| Xin, Chen |
NCT05882539: Oral Mucosal Pressure Injury in ICU Patients With Oral Tracheal Intubation |
|
|
| Recruiting | N/A | 471 | RoW | endotracheal tube material,Bite block Material, Moisture of oral mucosa, serum albumin level, mean arterial pressure level, blood lactate level, constraint, sedation, prone position, Duration of tracheal intubation | Second Affiliated Hospital, School of Medicine, Zhejiang University | Oral Mucosal Pressure Injury | 12/23 | 12/24 | | |
| jing, xu |
NCT05417841: Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM |
|
|
| Not yet recruiting | N/A | 224 | RoW | Insulin Degludec and Insulin Aspart Injection, Ryzodeg®, Insulin Aspart Injection, NovoRapid® | Beijing Hospital | Type 2 Diabetes Mellitus | 12/23 | 07/24 | | |
| wu, liu chao |
| No trials found |
| nan, su |
| No trials found |
| xia, yu hong |
| No trials found |
| tao, wang |
| No trials found |
| jiang, yuan |
| No trials found |
